177 related articles for article (PubMed ID: 23396259)
21. A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin.
Ghosh I; Michniak-Kohn B
Drug Dev Ind Pharm; 2012 Nov; 38(11):1408-16. PubMed ID: 22296239
[TBL] [Abstract][Full Text] [Related]
22. Hydroxypropyl methylcellulose mediated precipitation inhibition of sirolimus: from a screening campaign to a proof-of-concept human study.
Petruševska M; Homar M; Petek B; Resman A; Kocjan D; Urleb U; Peternel L
Mol Pharm; 2013 Jun; 10(6):2299-310. PubMed ID: 23586335
[TBL] [Abstract][Full Text] [Related]
23. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
Gosangari S; Dyakonov T
Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
[TBL] [Abstract][Full Text] [Related]
24. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
[TBL] [Abstract][Full Text] [Related]
25. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364.
Sotthivirat S; McKelvey C; Moser J; Rege B; Xu W; Zhang D
Int J Pharm; 2013 Aug; 452(1-2):73-81. PubMed ID: 23651642
[TBL] [Abstract][Full Text] [Related]
26. Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement.
Ghosh I; Michniak-Kohn B
Int J Pharm; 2012 Sep; 434(1-2):90-8. PubMed ID: 22633930
[TBL] [Abstract][Full Text] [Related]
27. The in vitro dissolution of theophylline from different types of hard shell capsules.
Podczeck F; Jones BE
Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.
Vialpando M; Smulders S; Bone S; Jager C; Vodak D; Van Speybroeck M; Verheyen L; Backx K; Boeykens P; Brewster ME; Ceulemans J; Novoa de Armas H; Van Geel K; Kesselaers E; Hillewaert V; Lachau-Durand S; Meurs G; Psathas P; Van Hove B; Verreck G; Voets M; Weuts I; Mackie C
J Pharm Sci; 2016 Sep; 105(9):2782-2793. PubMed ID: 27113473
[TBL] [Abstract][Full Text] [Related]
29. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
30. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
31. Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice.
Ho PY; Yeh TK; Yao HT; Lin HL; Wu HY; Lo YK; Chang YW; Chiang TH; Wu SH; Chao YS; Chen CT
Int J Pharm; 2008 Jul; 359(1-2):174-81. PubMed ID: 18513900
[TBL] [Abstract][Full Text] [Related]
32. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
33. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
Suys EJA; Chalmers DK; Pouton CW; Porter CJH
Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
[TBL] [Abstract][Full Text] [Related]
34. Oral absorption of atorvastatin solid dispersion based on cellulose or pyrrolidone derivative polymers.
Kim MS; Kim JS; Cho W; Park HJ; Hwang SJ
Int J Biol Macromol; 2013 Aug; 59():138-42. PubMed ID: 23567288
[TBL] [Abstract][Full Text] [Related]
35. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.
Jin F; Tatavarti A
Int J Pharm; 2010 Apr; 389(1-2):58-65. PubMed ID: 20083178
[TBL] [Abstract][Full Text] [Related]
36. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
[TBL] [Abstract][Full Text] [Related]
37. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.
Zhao L; Feng SS
J Pharm Sci; 2010 Aug; 99(8):3552-60. PubMed ID: 20564384
[TBL] [Abstract][Full Text] [Related]
38. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system.
Kim MS; Ha ES; Choo GH; Baek IH
Int J Mol Sci; 2015 May; 16(5):10821-33. PubMed ID: 25984604
[TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems.
Wang Y; Sun J; Zhang T; Liu H; He F; He Z
Drug Dev Ind Pharm; 2011 Oct; 37(10):1225-30. PubMed ID: 21615281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
